| |
| |
|
| Insider
Information: |
Paolini John F. |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
52,038 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,315,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,038 |
|
|
| Total
Value |
$1,315,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-09-03 |
52,038 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
SVP & Chief Medical Officer |
• – – |
2020-02-13 |
4 |
AS |
$18.29 |
$187,966 |
D/D |
(10,277) |
18,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
SVP & Chief Medical Officer |
• – – |
2020-02-14 |
4 |
AS |
$18.33 |
$19,045 |
D/D |
(1,039) |
18,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
SVP & Chief Medical Officer |
• – – |
2020-02-19 |
4 |
AS |
$18.27 |
$410,655 |
D/D |
(22,477) |
18,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
SVP & Chief Medical Officer |
• – – |
2020-02-20 |
4 |
AS |
$18.91 |
$185,832 |
D/D |
(9,803) |
18,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2022-11-07 |
4 |
AS |
$15.18 |
$430,459 |
D/D |
(28,357) |
36,335 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-07-25 |
4 |
AS |
$18.01 |
$555,160 |
D/D |
(29,000) |
41,910 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-09-05 |
4 |
AS |
$17.53 |
$7,012 |
D/D |
(400) |
44,892 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-12-07 |
4 |
AS |
$17.54 |
$504,758 |
D/D |
(28,600) |
44,892 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-02-27 |
4 |
AS |
$21.03 |
$213,581 |
D/D |
(10,156) |
44,892 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-03-01 |
4 |
AS |
$21.77 |
$410,234 |
D/D |
(18,844) |
44,892 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-07-23 |
4 |
AS |
$25.03 |
$578,966 |
D/D |
(22,000) |
47,803 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-09-03 |
4 |
AS |
$26.09 |
$1,584,991 |
D/D |
(60,692) |
52,038 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Medical Officer |
• – – |
2022-03-16 |
4 |
D |
$10.13 |
$6,058 |
D/D |
(598) |
31,127 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2022-03-21 |
4 |
D |
$10.98 |
$18,512 |
D/D |
(1,686) |
35,117 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2022-09-02 |
4 |
D |
$11.44 |
$5,800 |
D/D |
(507) |
36,335 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-03-16 |
4 |
D |
$11.46 |
$5,810 |
D/D |
(507) |
37,553 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-03-20 |
4 |
D |
$11.12 |
$11,987 |
D/D |
(1,078) |
40,146 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-04-10 |
4 |
D |
$10.71 |
$7,861 |
D/D |
(734) |
41,910 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-09-01 |
4 |
D |
$17.76 |
$13,036 |
D/D |
(734) |
43,674 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2023-09-02 |
4 |
D |
$17.76 |
$9,004 |
D/D |
(507) |
44,892 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$19.70 |
$9,397 |
D/D |
(477) |
46,039 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-04-08 |
4 |
D |
$17.90 |
$13,121 |
D/D |
(733) |
47,803 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-09-01 |
4 |
D |
$26.74 |
$53,320 |
D/D |
(1,994) |
51,148 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF MEDICAL OFFICER |
• – – |
2024-09-02 |
4 |
D |
$26.74 |
$22,328 |
D/D |
(835) |
52,038 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
SVP & Chief Medical Officer |
• – – |
2019-10-07 |
4 |
OE |
$1.86 |
$18,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
